We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Group A Streptococcus Rapid Immunoassay Evaluated

By LabMedica International staff writers
Posted on 27 Apr 2016
Print article
Image: The TestPack Strep A test is a simple rapid immunochromatographic assay for the qualitative detection of Group A Strep antigen from throat swabs (Photo courtesy of Alere).
Image: The TestPack Strep A test is a simple rapid immunochromatographic assay for the qualitative detection of Group A Strep antigen from throat swabs (Photo courtesy of Alere).
Clinical reasoning utilizing certain symptoms and scores has not proven to be a reliable decision-making tool to determine whether or not to suspect a group A Streptococcus (GAS) infection in the patient presenting with a sore throat.

An excellent solution for this dilemma would be a bedside rapid antigen detection test (RADT) for GAS that provides a positive or negative result within five to 10 minutes, thus directly influencing the treatment decision. Such RADTs have been evaluated previously using throat culture as the gold standard and initially showed insufficient sensitivity and specificity.

Scientists at North West Hospital and Health Service (Mount Isa, QLD, Australia) collected throat swab samples from patients attending the Mount Isa Hospital emergency department for a sore throat; these samples were compared to swab samples collected from healthy controls that did not have a sore throat and both groups were aged three to 15 years. None of these children had previously had rheumatic fever.

The study team processed the swabs within 72 hours using the Alere Test Pack +Plus with OBC Strep A kit (Alere, Waltham, MA, USA). This test kit had shown a 95% to 97% sensitivity and a specificity of 95% to 100% to detect GAS. In this study the outcomes were compared with the assumption that the sensitivity of the point-of-care test was 95% and with the assumption that the sensitivity was 97%. The treating clinician was blinded to the point-of-care test result.

From June 30, 2014 to February 27, 2015, 248 throat swabs were collected and examined within 72 hours. Out of the 101 patients presenting with a sore throat, 26 (26%) tested positive for GAS. Only one (0.7%) of the 147 control patients had a positive test result. Statistical analysis showed both the positive and negative etiologic predictive value (EPV) to be high. The 95% confidence interval for positive EPV was 88% to 100% and for negative EPV was 97% to 99%, depending on assumptions made.

The authors concluded that their study demonstrated that the point-of-care test Alere Test Pack +Plus Strep A has a high positive predictive value and was able to rule in GAS infection as long as the proportion of carriers is low. Also the negative predictive value for ruling out GAS as the etiologic agent is very high irrespective of the carrier rate. Hence, this test is always useful to rule out GAS infection. The study was published in the April 2016 issue of the International Journal of Infectious Diseases.

Related Links:
North West Hospital and Health Service
Alere
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.